A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Safety and Efficacy of VM202 in Subjects With Painful Diabetic Peripheral Neuropathy
Phase of Trial: Phase II
Latest Information Update: 31 Jan 2018
At a glance
- Drugs Donaperminogene seltoplasmid (Primary)
- Indications Diabetic neuropathies
- Focus Therapeutic Use
- Sponsors ViroMed
- 06 Mar 2015 Results published in a media release and in the journal Annals of Clinical and Translational Neurology.
- 18 Jan 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 22 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History